retatrutide trial doses microdosing: guide to split dosing protocols and schedules retatrutide safety clinical trials A
Description
More recently, the SELECT trial evaluated overweight patients with CVD but without T2DM
We don't do that with other disease processes
This involves ceasing Tirzepatide administration and allowing a sufficient amount of time for the compound to be largely cleared from the system
Podolski, BS, MS
Semaglutide Wegovy Ozempic 15-17% weight loss 1 pathway Tirzepatide Mounjaro Zepbound 20-22% weight loss 2 pathways Retatrutide Latest generation 24%+ weight loss 3 pathways Outcomes based on published clinical research at maintenance doses
